nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—ABCB1—Dactinomycin—testicular cancer	0.114	0.284	CbGbCtD
Scopolamine—ABCB1—Vinblastine—testicular cancer	0.0714	0.178	CbGbCtD
Scopolamine—ABCB1—Cisplatin—testicular cancer	0.0655	0.163	CbGbCtD
Scopolamine—ABCB1—Etoposide—testicular cancer	0.0643	0.16	CbGbCtD
Scopolamine—ABCB1—Doxorubicin—testicular cancer	0.0439	0.109	CbGbCtD
Scopolamine—ABCB1—Methotrexate—testicular cancer	0.0425	0.106	CbGbCtD
Scopolamine—Visual impairment—Ifosfamide—testicular cancer	0.00338	0.00564	CcSEcCtD
Scopolamine—Erythema—Dactinomycin—testicular cancer	0.00333	0.00556	CcSEcCtD
Scopolamine—Eye disorder—Ifosfamide—testicular cancer	0.00328	0.00547	CcSEcCtD
Scopolamine—Conjunctivitis—Cisplatin—testicular cancer	0.00327	0.00547	CcSEcCtD
Scopolamine—Flushing—Ifosfamide—testicular cancer	0.00325	0.00544	CcSEcCtD
Scopolamine—Fatigue—Chlorambucil—testicular cancer	0.00325	0.00542	CcSEcCtD
Scopolamine—Pain—Chlorambucil—testicular cancer	0.00322	0.00538	CcSEcCtD
Scopolamine—Depressed level of consciousness—Methotrexate—testicular cancer	0.00319	0.00533	CcSEcCtD
Scopolamine—Arrhythmia—Ifosfamide—testicular cancer	0.00313	0.00523	CcSEcCtD
Scopolamine—Feeling abnormal—Chlorambucil—testicular cancer	0.0031	0.00518	CcSEcCtD
Scopolamine—Bradycardia—Cisplatin—testicular cancer	0.00308	0.00514	CcSEcCtD
Scopolamine—Mental disorder—Ifosfamide—testicular cancer	0.00307	0.00513	CcSEcCtD
Scopolamine—Erythema—Ifosfamide—testicular cancer	0.00305	0.0051	CcSEcCtD
Scopolamine—Urinary tract disorder—Cisplatin—testicular cancer	0.00298	0.00499	CcSEcCtD
Scopolamine—Abdominal pain—Chlorambucil—testicular cancer	0.00298	0.00497	CcSEcCtD
Scopolamine—Body temperature increased—Chlorambucil—testicular cancer	0.00298	0.00497	CcSEcCtD
Scopolamine—Urethral disorder—Cisplatin—testicular cancer	0.00296	0.00495	CcSEcCtD
Scopolamine—Pain—Vinblastine—testicular cancer	0.00295	0.00493	CcSEcCtD
Scopolamine—Constipation—Vinblastine—testicular cancer	0.00295	0.00493	CcSEcCtD
Scopolamine—Confusional state—Bleomycin—testicular cancer	0.00294	0.00491	CcSEcCtD
Scopolamine—Oedema—Bleomycin—testicular cancer	0.00291	0.00487	CcSEcCtD
Scopolamine—Visual impairment—Cisplatin—testicular cancer	0.00291	0.00487	CcSEcCtD
Scopolamine—Vision blurred—Ifosfamide—testicular cancer	0.00288	0.0048	CcSEcCtD
Scopolamine—Dry eye—Epirubicin—testicular cancer	0.00285	0.00477	CcSEcCtD
Scopolamine—Feeling abnormal—Vinblastine—testicular cancer	0.00284	0.00475	CcSEcCtD
Scopolamine—Eye disorder—Cisplatin—testicular cancer	0.00282	0.00472	CcSEcCtD
Scopolamine—Flushing—Cisplatin—testicular cancer	0.00281	0.00469	CcSEcCtD
Scopolamine—Agitation—Ifosfamide—testicular cancer	0.0028	0.00469	CcSEcCtD
Scopolamine—Vertigo—Ifosfamide—testicular cancer	0.00274	0.00458	CcSEcCtD
Scopolamine—Urinary tract disorder—Etoposide—testicular cancer	0.00273	0.00457	CcSEcCtD
Scopolamine—Abdominal pain—Vinblastine—testicular cancer	0.00273	0.00456	CcSEcCtD
Scopolamine—Hypotension—Bleomycin—testicular cancer	0.00272	0.00455	CcSEcCtD
Scopolamine—Oedema—Dactinomycin—testicular cancer	0.00272	0.00454	CcSEcCtD
Scopolamine—Urethral disorder—Etoposide—testicular cancer	0.00271	0.00453	CcSEcCtD
Scopolamine—Asthenia—Chlorambucil—testicular cancer	0.0027	0.00451	CcSEcCtD
Scopolamine—Arrhythmia—Cisplatin—testicular cancer	0.0027	0.00451	CcSEcCtD
Scopolamine—Pruritus—Chlorambucil—testicular cancer	0.00266	0.00445	CcSEcCtD
Scopolamine—Dry eye—Doxorubicin—testicular cancer	0.00264	0.00441	CcSEcCtD
Scopolamine—Erythema—Cisplatin—testicular cancer	0.00263	0.0044	CcSEcCtD
Scopolamine—Eye disorder—Etoposide—testicular cancer	0.00259	0.00432	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.00258	0.00431	CcSEcCtD
Scopolamine—Flushing—Etoposide—testicular cancer	0.00257	0.00429	CcSEcCtD
Scopolamine—Confusional state—Ifosfamide—testicular cancer	0.00251	0.0042	CcSEcCtD
Scopolamine—Eczema—Epirubicin—testicular cancer	0.0025	0.00417	CcSEcCtD
Scopolamine—Pain—Bleomycin—testicular cancer	0.00249	0.00416	CcSEcCtD
Scopolamine—Oedema—Ifosfamide—testicular cancer	0.00249	0.00416	CcSEcCtD
Scopolamine—Vision blurred—Cisplatin—testicular cancer	0.00248	0.00414	CcSEcCtD
Scopolamine—Asthenia—Vinblastine—testicular cancer	0.00248	0.00414	CcSEcCtD
Scopolamine—Tremor—Cisplatin—testicular cancer	0.00247	0.00412	CcSEcCtD
Scopolamine—Nervous system disorder—Ifosfamide—testicular cancer	0.00244	0.00408	CcSEcCtD
Scopolamine—Skin disorder—Ifosfamide—testicular cancer	0.00242	0.00404	CcSEcCtD
Scopolamine—Hyperhidrosis—Ifosfamide—testicular cancer	0.00241	0.00402	CcSEcCtD
Scopolamine—Feeling abnormal—Bleomycin—testicular cancer	0.0024	0.00401	CcSEcCtD
Scopolamine—Vomiting—Chlorambucil—testicular cancer	0.00239	0.004	CcSEcCtD
Scopolamine—Fatigue—Dactinomycin—testicular cancer	0.00234	0.00391	CcSEcCtD
Scopolamine—Hypotension—Ifosfamide—testicular cancer	0.00233	0.00389	CcSEcCtD
Scopolamine—Pain—Dactinomycin—testicular cancer	0.00232	0.00388	CcSEcCtD
Scopolamine—Eczema—Doxorubicin—testicular cancer	0.00231	0.00386	CcSEcCtD
Scopolamine—Body temperature increased—Bleomycin—testicular cancer	0.0023	0.00385	CcSEcCtD
Scopolamine—Irritability—Methotrexate—testicular cancer	0.00229	0.00382	CcSEcCtD
Scopolamine—Dizziness—Vinblastine—testicular cancer	0.00228	0.00381	CcSEcCtD
Scopolamine—Feeling abnormal—Dactinomycin—testicular cancer	0.00224	0.00374	CcSEcCtD
Scopolamine—Nausea—Chlorambucil—testicular cancer	0.00224	0.00374	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.00222	0.00372	CcSEcCtD
Scopolamine—Somnolence—Ifosfamide—testicular cancer	0.00221	0.0037	CcSEcCtD
Scopolamine—Vomiting—Vinblastine—testicular cancer	0.00219	0.00367	CcSEcCtD
Scopolamine—Vertigo—Etoposide—testicular cancer	0.00217	0.00362	CcSEcCtD
Scopolamine—Headache—Vinblastine—testicular cancer	0.00216	0.00361	CcSEcCtD
Scopolamine—Abdominal pain—Dactinomycin—testicular cancer	0.00215	0.00359	CcSEcCtD
Scopolamine—Body temperature increased—Dactinomycin—testicular cancer	0.00215	0.00359	CcSEcCtD
Scopolamine—Fatigue—Ifosfamide—testicular cancer	0.00215	0.00359	CcSEcCtD
Scopolamine—Oedema—Cisplatin—testicular cancer	0.00215	0.00359	CcSEcCtD
Scopolamine—Pain—Ifosfamide—testicular cancer	0.00213	0.00356	CcSEcCtD
Scopolamine—Constipation—Ifosfamide—testicular cancer	0.00213	0.00356	CcSEcCtD
Scopolamine—Nervous system disorder—Cisplatin—testicular cancer	0.00211	0.00352	CcSEcCtD
Scopolamine—Tachycardia—Cisplatin—testicular cancer	0.0021	0.0035	CcSEcCtD
Scopolamine—Asthenia—Bleomycin—testicular cancer	0.00209	0.00349	CcSEcCtD
Scopolamine—Skin disorder—Cisplatin—testicular cancer	0.00209	0.00348	CcSEcCtD
Scopolamine—Hyperhidrosis—Cisplatin—testicular cancer	0.00208	0.00347	CcSEcCtD
Scopolamine—Pruritus—Bleomycin—testicular cancer	0.00206	0.00344	CcSEcCtD
Scopolamine—Dry skin—Epirubicin—testicular cancer	0.00206	0.00344	CcSEcCtD
Scopolamine—Feeling abnormal—Ifosfamide—testicular cancer	0.00205	0.00343	CcSEcCtD
Scopolamine—Nausea—Vinblastine—testicular cancer	0.00205	0.00342	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00204	0.0034	CcSEcCtD
Scopolamine—Hypotension—Cisplatin—testicular cancer	0.00201	0.00335	CcSEcCtD
Scopolamine—Confusional state—Etoposide—testicular cancer	0.00198	0.00331	CcSEcCtD
Scopolamine—Muscular weakness—Epirubicin—testicular cancer	0.00198	0.00331	CcSEcCtD
Scopolamine—Body temperature increased—Ifosfamide—testicular cancer	0.00197	0.00329	CcSEcCtD
Scopolamine—Abdominal pain—Ifosfamide—testicular cancer	0.00197	0.00329	CcSEcCtD
Scopolamine—Asthenia—Dactinomycin—testicular cancer	0.00195	0.00326	CcSEcCtD
Scopolamine—Dysphagia—Epirubicin—testicular cancer	0.00194	0.00324	CcSEcCtD
Scopolamine—Dysuria—Methotrexate—testicular cancer	0.00194	0.00324	CcSEcCtD
Scopolamine—Tachycardia—Etoposide—testicular cancer	0.00192	0.00321	CcSEcCtD
Scopolamine—Skin disorder—Etoposide—testicular cancer	0.00191	0.00319	CcSEcCtD
Scopolamine—Dry skin—Doxorubicin—testicular cancer	0.0019	0.00318	CcSEcCtD
Scopolamine—Hyperhidrosis—Etoposide—testicular cancer	0.0019	0.00318	CcSEcCtD
Scopolamine—Vomiting—Bleomycin—testicular cancer	0.00185	0.0031	CcSEcCtD
Scopolamine—Drowsiness—Methotrexate—testicular cancer	0.00185	0.00309	CcSEcCtD
Scopolamine—Hypotension—Etoposide—testicular cancer	0.00184	0.00307	CcSEcCtD
Scopolamine—Rash—Bleomycin—testicular cancer	0.00184	0.00307	CcSEcCtD
Scopolamine—Pain—Cisplatin—testicular cancer	0.00184	0.00307	CcSEcCtD
Scopolamine—Dermatitis—Bleomycin—testicular cancer	0.00184	0.00307	CcSEcCtD
Scopolamine—Muscular weakness—Doxorubicin—testicular cancer	0.00183	0.00306	CcSEcCtD
Scopolamine—Dysuria—Epirubicin—testicular cancer	0.00181	0.00303	CcSEcCtD
Scopolamine—Conjunctivitis—Methotrexate—testicular cancer	0.0018	0.003	CcSEcCtD
Scopolamine—Dysphagia—Doxorubicin—testicular cancer	0.00179	0.003	CcSEcCtD
Scopolamine—Asthenia—Ifosfamide—testicular cancer	0.00179	0.00299	CcSEcCtD
Scopolamine—Sweating—Methotrexate—testicular cancer	0.00177	0.00296	CcSEcCtD
Scopolamine—Feeling abnormal—Cisplatin—testicular cancer	0.00177	0.00296	CcSEcCtD
Scopolamine—Pruritus—Ifosfamide—testicular cancer	0.00176	0.00294	CcSEcCtD
Scopolamine—Somnolence—Etoposide—testicular cancer	0.00175	0.00292	CcSEcCtD
Scopolamine—Nausea—Bleomycin—testicular cancer	0.00173	0.00289	CcSEcCtD
Scopolamine—Drowsiness—Epirubicin—testicular cancer	0.00173	0.00289	CcSEcCtD
Scopolamine—Vomiting—Dactinomycin—testicular cancer	0.00173	0.00289	CcSEcCtD
Scopolamine—Rash—Dactinomycin—testicular cancer	0.00171	0.00286	CcSEcCtD
Scopolamine—Body temperature increased—Cisplatin—testicular cancer	0.0017	0.00284	CcSEcCtD
Scopolamine—Fatigue—Etoposide—testicular cancer	0.0017	0.00283	CcSEcCtD
Scopolamine—Constipation—Etoposide—testicular cancer	0.00168	0.00281	CcSEcCtD
Scopolamine—Pain—Etoposide—testicular cancer	0.00168	0.00281	CcSEcCtD
Scopolamine—Conjunctivitis—Epirubicin—testicular cancer	0.00168	0.00281	CcSEcCtD
Scopolamine—Dysuria—Doxorubicin—testicular cancer	0.00168	0.0028	CcSEcCtD
Scopolamine—Sweating—Epirubicin—testicular cancer	0.00166	0.00277	CcSEcCtD
Scopolamine—Dizziness—Ifosfamide—testicular cancer	0.00165	0.00275	CcSEcCtD
Scopolamine—Pharyngitis—Methotrexate—testicular cancer	0.00165	0.00275	CcSEcCtD
Scopolamine—Urinary tract disorder—Methotrexate—testicular cancer	0.00164	0.00274	CcSEcCtD
Scopolamine—Urethral disorder—Methotrexate—testicular cancer	0.00163	0.00272	CcSEcCtD
Scopolamine—Feeling abnormal—Etoposide—testicular cancer	0.00162	0.00271	CcSEcCtD
Scopolamine—Nausea—Dactinomycin—testicular cancer	0.00161	0.0027	CcSEcCtD
Scopolamine—Drowsiness—Doxorubicin—testicular cancer	0.0016	0.00267	CcSEcCtD
Scopolamine—Visual impairment—Methotrexate—testicular cancer	0.0016	0.00267	CcSEcCtD
Scopolamine—Vomiting—Ifosfamide—testicular cancer	0.00158	0.00265	CcSEcCtD
Scopolamine—Bradycardia—Epirubicin—testicular cancer	0.00158	0.00264	CcSEcCtD
Scopolamine—Rash—Ifosfamide—testicular cancer	0.00157	0.00262	CcSEcCtD
Scopolamine—Dermatitis—Ifosfamide—testicular cancer	0.00157	0.00262	CcSEcCtD
Scopolamine—Body temperature increased—Etoposide—testicular cancer	0.00156	0.0026	CcSEcCtD
Scopolamine—Abdominal pain—Etoposide—testicular cancer	0.00156	0.0026	CcSEcCtD
Scopolamine—Conjunctivitis—Doxorubicin—testicular cancer	0.00156	0.0026	CcSEcCtD
Scopolamine—Eye disorder—Methotrexate—testicular cancer	0.00155	0.00259	CcSEcCtD
Scopolamine—Asthenia—Cisplatin—testicular cancer	0.00154	0.00257	CcSEcCtD
Scopolamine—Pharyngitis—Epirubicin—testicular cancer	0.00154	0.00257	CcSEcCtD
Scopolamine—Sweating—Doxorubicin—testicular cancer	0.00153	0.00256	CcSEcCtD
Scopolamine—Urinary tract disorder—Epirubicin—testicular cancer	0.00153	0.00256	CcSEcCtD
Scopolamine—Urethral disorder—Epirubicin—testicular cancer	0.00152	0.00254	CcSEcCtD
Scopolamine—Visual impairment—Epirubicin—testicular cancer	0.0015	0.0025	CcSEcCtD
Scopolamine—Nausea—Ifosfamide—testicular cancer	0.00148	0.00247	CcSEcCtD
Scopolamine—Bradycardia—Doxorubicin—testicular cancer	0.00146	0.00244	CcSEcCtD
Scopolamine—Mental disorder—Methotrexate—testicular cancer	0.00145	0.00243	CcSEcCtD
Scopolamine—Eye disorder—Epirubicin—testicular cancer	0.00145	0.00242	CcSEcCtD
Scopolamine—Erythema—Methotrexate—testicular cancer	0.00144	0.00241	CcSEcCtD
Scopolamine—Flushing—Epirubicin—testicular cancer	0.00144	0.00241	CcSEcCtD
Scopolamine—Pharyngitis—Doxorubicin—testicular cancer	0.00143	0.00238	CcSEcCtD
Scopolamine—Urinary tract disorder—Doxorubicin—testicular cancer	0.00142	0.00237	CcSEcCtD
Scopolamine—Asthenia—Etoposide—testicular cancer	0.00141	0.00236	CcSEcCtD
Scopolamine—Urethral disorder—Doxorubicin—testicular cancer	0.00141	0.00235	CcSEcCtD
Scopolamine—Pruritus—Etoposide—testicular cancer	0.00139	0.00232	CcSEcCtD
Scopolamine—Arrhythmia—Epirubicin—testicular cancer	0.00139	0.00232	CcSEcCtD
Scopolamine—Visual impairment—Doxorubicin—testicular cancer	0.00138	0.00231	CcSEcCtD
Scopolamine—Vomiting—Cisplatin—testicular cancer	0.00137	0.00228	CcSEcCtD
Scopolamine—Vision blurred—Methotrexate—testicular cancer	0.00136	0.00227	CcSEcCtD
Scopolamine—Mental disorder—Epirubicin—testicular cancer	0.00136	0.00227	CcSEcCtD
Scopolamine—Rash—Cisplatin—testicular cancer	0.00135	0.00226	CcSEcCtD
Scopolamine—Dermatitis—Cisplatin—testicular cancer	0.00135	0.00226	CcSEcCtD
Scopolamine—Erythema—Epirubicin—testicular cancer	0.00135	0.00226	CcSEcCtD
Scopolamine—Eye disorder—Doxorubicin—testicular cancer	0.00134	0.00224	CcSEcCtD
Scopolamine—Flushing—Doxorubicin—testicular cancer	0.00133	0.00223	CcSEcCtD
Scopolamine—Dizziness—Etoposide—testicular cancer	0.0013	0.00217	CcSEcCtD
Scopolamine—Vertigo—Methotrexate—testicular cancer	0.0013	0.00217	CcSEcCtD
Scopolamine—Arrhythmia—Doxorubicin—testicular cancer	0.00128	0.00214	CcSEcCtD
Scopolamine—Nausea—Cisplatin—testicular cancer	0.00128	0.00213	CcSEcCtD
Scopolamine—Vision blurred—Epirubicin—testicular cancer	0.00127	0.00213	CcSEcCtD
Scopolamine—Mental disorder—Doxorubicin—testicular cancer	0.00126	0.0021	CcSEcCtD
Scopolamine—Vomiting—Etoposide—testicular cancer	0.00125	0.00209	CcSEcCtD
Scopolamine—Erythema—Doxorubicin—testicular cancer	0.00125	0.00209	CcSEcCtD
Scopolamine—Agitation—Epirubicin—testicular cancer	0.00124	0.00207	CcSEcCtD
Scopolamine—Rash—Etoposide—testicular cancer	0.00124	0.00207	CcSEcCtD
Scopolamine—Dermatitis—Etoposide—testicular cancer	0.00124	0.00207	CcSEcCtD
Scopolamine—Headache—Etoposide—testicular cancer	0.00123	0.00206	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.00122	0.00204	CcSEcCtD
Scopolamine—Vertigo—Epirubicin—testicular cancer	0.00121	0.00203	CcSEcCtD
Scopolamine—Confusional state—Methotrexate—testicular cancer	0.00119	0.00198	CcSEcCtD
Scopolamine—Vision blurred—Doxorubicin—testicular cancer	0.00118	0.00197	CcSEcCtD
Scopolamine—Nausea—Etoposide—testicular cancer	0.00117	0.00195	CcSEcCtD
Scopolamine—Nervous system disorder—Methotrexate—testicular cancer	0.00116	0.00193	CcSEcCtD
Scopolamine—Agitation—Doxorubicin—testicular cancer	0.00115	0.00192	CcSEcCtD
Scopolamine—Skin disorder—Methotrexate—testicular cancer	0.00114	0.00191	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00114	0.00191	CcSEcCtD
Scopolamine—Hyperhidrosis—Methotrexate—testicular cancer	0.00114	0.0019	CcSEcCtD
Scopolamine—Dry mouth—Epirubicin—testicular cancer	0.00113	0.00188	CcSEcCtD
Scopolamine—Vertigo—Doxorubicin—testicular cancer	0.00112	0.00188	CcSEcCtD
Scopolamine—Confusional state—Epirubicin—testicular cancer	0.00111	0.00186	CcSEcCtD
Scopolamine—Oedema—Epirubicin—testicular cancer	0.0011	0.00184	CcSEcCtD
Scopolamine—Hypotension—Methotrexate—testicular cancer	0.0011	0.00184	CcSEcCtD
Scopolamine—Nervous system disorder—Epirubicin—testicular cancer	0.00108	0.00181	CcSEcCtD
Scopolamine—Tachycardia—Epirubicin—testicular cancer	0.00108	0.0018	CcSEcCtD
Scopolamine—Skin disorder—Epirubicin—testicular cancer	0.00107	0.00179	CcSEcCtD
Scopolamine—Hyperhidrosis—Epirubicin—testicular cancer	0.00107	0.00178	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.00106	0.00177	CcSEcCtD
Scopolamine—Somnolence—Methotrexate—testicular cancer	0.00105	0.00175	CcSEcCtD
Scopolamine—Dry mouth—Doxorubicin—testicular cancer	0.00104	0.00174	CcSEcCtD
Scopolamine—Hypotension—Epirubicin—testicular cancer	0.00103	0.00172	CcSEcCtD
Scopolamine—Confusional state—Doxorubicin—testicular cancer	0.00103	0.00172	CcSEcCtD
Scopolamine—Oedema—Doxorubicin—testicular cancer	0.00102	0.0017	CcSEcCtD
Scopolamine—Fatigue—Methotrexate—testicular cancer	0.00102	0.0017	CcSEcCtD
Scopolamine—Pain—Methotrexate—testicular cancer	0.00101	0.00168	CcSEcCtD
Scopolamine—Nervous system disorder—Doxorubicin—testicular cancer	0.001	0.00167	CcSEcCtD
Scopolamine—Tachycardia—Doxorubicin—testicular cancer	0.000996	0.00166	CcSEcCtD
Scopolamine—Skin disorder—Doxorubicin—testicular cancer	0.000991	0.00166	CcSEcCtD
Scopolamine—Hyperhidrosis—Doxorubicin—testicular cancer	0.000986	0.00165	CcSEcCtD
Scopolamine—Somnolence—Epirubicin—testicular cancer	0.00098	0.00164	CcSEcCtD
Scopolamine—Feeling abnormal—Methotrexate—testicular cancer	0.000971	0.00162	CcSEcCtD
Scopolamine—Hypotension—Doxorubicin—testicular cancer	0.000953	0.00159	CcSEcCtD
Scopolamine—Fatigue—Epirubicin—testicular cancer	0.000951	0.00159	CcSEcCtD
Scopolamine—Constipation—Epirubicin—testicular cancer	0.000943	0.00158	CcSEcCtD
Scopolamine—Pain—Epirubicin—testicular cancer	0.000943	0.00158	CcSEcCtD
Scopolamine—Body temperature increased—Methotrexate—testicular cancer	0.000932	0.00156	CcSEcCtD
Scopolamine—Abdominal pain—Methotrexate—testicular cancer	0.000932	0.00156	CcSEcCtD
Scopolamine—Feeling abnormal—Epirubicin—testicular cancer	0.000909	0.00152	CcSEcCtD
Scopolamine—Somnolence—Doxorubicin—testicular cancer	0.000907	0.00152	CcSEcCtD
Scopolamine—Fatigue—Doxorubicin—testicular cancer	0.00088	0.00147	CcSEcCtD
Scopolamine—Pain—Doxorubicin—testicular cancer	0.000873	0.00146	CcSEcCtD
Scopolamine—Constipation—Doxorubicin—testicular cancer	0.000873	0.00146	CcSEcCtD
Scopolamine—Abdominal pain—Epirubicin—testicular cancer	0.000872	0.00146	CcSEcCtD
Scopolamine—Body temperature increased—Epirubicin—testicular cancer	0.000872	0.00146	CcSEcCtD
Scopolamine—Asthenia—Methotrexate—testicular cancer	0.000845	0.00141	CcSEcCtD
Scopolamine—Feeling abnormal—Doxorubicin—testicular cancer	0.000841	0.0014	CcSEcCtD
Scopolamine—Pruritus—Methotrexate—testicular cancer	0.000834	0.00139	CcSEcCtD
Scopolamine—Abdominal pain—Doxorubicin—testicular cancer	0.000807	0.00135	CcSEcCtD
Scopolamine—Body temperature increased—Doxorubicin—testicular cancer	0.000807	0.00135	CcSEcCtD
Scopolamine—Asthenia—Epirubicin—testicular cancer	0.000791	0.00132	CcSEcCtD
Scopolamine—Pruritus—Epirubicin—testicular cancer	0.00078	0.0013	CcSEcCtD
Scopolamine—Dizziness—Methotrexate—testicular cancer	0.000779	0.0013	CcSEcCtD
Scopolamine—Vomiting—Methotrexate—testicular cancer	0.000749	0.00125	CcSEcCtD
Scopolamine—Rash—Methotrexate—testicular cancer	0.000743	0.00124	CcSEcCtD
Scopolamine—Dermatitis—Methotrexate—testicular cancer	0.000742	0.00124	CcSEcCtD
Scopolamine—Headache—Methotrexate—testicular cancer	0.000738	0.00123	CcSEcCtD
Scopolamine—Asthenia—Doxorubicin—testicular cancer	0.000732	0.00122	CcSEcCtD
Scopolamine—Dizziness—Epirubicin—testicular cancer	0.000729	0.00122	CcSEcCtD
Scopolamine—Pruritus—Doxorubicin—testicular cancer	0.000722	0.00121	CcSEcCtD
Scopolamine—Vomiting—Epirubicin—testicular cancer	0.000701	0.00117	CcSEcCtD
Scopolamine—Nausea—Methotrexate—testicular cancer	0.0007	0.00117	CcSEcCtD
Scopolamine—Rash—Epirubicin—testicular cancer	0.000695	0.00116	CcSEcCtD
Scopolamine—Dermatitis—Epirubicin—testicular cancer	0.000695	0.00116	CcSEcCtD
Scopolamine—Headache—Epirubicin—testicular cancer	0.000691	0.00115	CcSEcCtD
Scopolamine—Dizziness—Doxorubicin—testicular cancer	0.000675	0.00113	CcSEcCtD
Scopolamine—Nausea—Epirubicin—testicular cancer	0.000655	0.00109	CcSEcCtD
Scopolamine—Vomiting—Doxorubicin—testicular cancer	0.000649	0.00108	CcSEcCtD
Scopolamine—Rash—Doxorubicin—testicular cancer	0.000643	0.00107	CcSEcCtD
Scopolamine—Dermatitis—Doxorubicin—testicular cancer	0.000643	0.00107	CcSEcCtD
Scopolamine—Headache—Doxorubicin—testicular cancer	0.000639	0.00107	CcSEcCtD
Scopolamine—Nausea—Doxorubicin—testicular cancer	0.000606	0.00101	CcSEcCtD
